X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-18 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale | $10.19 | -6,498 | 118,817 | -5% | -$66,215 | ||||||
2025-02-18 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $10.19 | -4,380 | 118,178 | -4% | -$44,632 | ||||||
2025-02-18 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $10.19 | -1,537 | 50,102 | -3% | -$15,662 | ||||||
| M | 2025-02-18 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $4.55 | -50,374 | 1,232,988 | -4% | -$229,237 | |||||
2025-02-20 | RCEL | Avita Medical, Inc. | McNamara Robert | Dir | P - Purchase | $10.09 | +10,000 | 45,749 | +28% | +$100,900 | ||||||
2025-02-20 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $9.90 | +1,000 | 25,734 | +4% | +$9,900 | ||||||
| M | 2025-02-18 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.79 | +53,845 | 15,949,849 | 0% | +$42,659 | |||||
2025-02-20 | NPCE | Neuropace Inc | Kck Ltd. | 10% | S - Sale | $9.40 | -5,270,845 | 0 | -100% | -$49,545,943 | ||||||
| D | 2025-02-18 | SYK | Stryker Corp | Golston Allan C. | Dir | S - Sale+OE | $383.07 | -2,458 | 14,895 | -14% | -$941,586 | |||||
2025-02-17 | MCAGU | Mountain Crest Acquisition Corp. V | Liu Suying | CEO, CFO, 10% | S - Sale | $7.00 | -100,000 | 2,065,800 | -5% | -$700,000 | ||||||
2025-02-17 | MCAGU | Mountain Crest Acquisition Corp. V | Mountain Crest Global Holdings LLC | 10% | S - Sale | $7.00 | -100,000 | 2,065,800 | -5% | -$700,000 | ||||||
2025-02-14 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $147.14 | -3,416 | 72,437 | -5% | -$502,630 | ||||||
2025-02-19 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $10.25 | +1,000 | 24,734 | +4% | +$10,250 | ||||||
| M | 2025-02-18 | BSX | Boston Scientific Corp | Sorenson John Bradley | EVP, Global Operations | S - Sale | $104.84 | -5,960 | 20,991 | -22% | -$624,861 | |||||
2025-02-19 | BSX | Boston Scientific Corp | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $105.35 | -1,510 | 33,129 | -4% | -$159,079 | ||||||
| DM | 2025-02-18 | BSX | Boston Scientific Corp | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $105.10 | -84,863 | 225,808 | -27% | -$8,919,296 | |||||
| D | 2025-02-13 | INSP | Inspire Medical Systems, Inc. | Ban Randy | See Remarks | S - Sale+OE | $183.50 | -25,584 | 7,592 | -77% | -$4,694,766 | |||||
| D | 2025-02-14 | BSX | Boston Scientific Corp | Sorenson John Bradley | EVP, Global Operations | S - Sale+OE | $106.31 | -1,201 | 26,951 | -4% | -$127,678 | |||||
2025-02-13 | MDXG | Mimedx Group, Inc. | Whitlow Ricci S | COO | S - Sale | $8.28 | -61,420 | 403,019 | -13% | -$508,558 | ||||||
2025-02-14 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, GC, CCO, CS | S - Sale | $4.11 | -18,965 | 369,682 | -5% | -$77,946 | ||||||
2025-02-14 | STIM | Neuronetics, Inc. | Furlong Stephen | EVP, CFO, Treasurer | S - Sale | $4.11 | -17,307 | 454,420 | -4% | -$71,132 | ||||||
| M | 2025-02-12 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.78 | +19,270 | 15,896,004 | 0% | +$14,974 | |||||
2025-02-14 | SSII | Ss Innovations International, Inc. | Adams Timothy P. | Dir | P - Purchase | $1.37 | +1,250,000 | 5,031,902 | +33% | +$1,715,000 | ||||||
2025-02-14 | SSII | Ss Innovations International, Inc. | Srivastava Sudhir | COB, CEO, 10% | S - Sale | $1.37 | -1,250,000 | 94,983,370 | -1% | -$1,715,000 | ||||||
2025-02-13 | EMBC | Embecta Corp. | Morris Milton Mayo | Dir | S - Sale | $16.38 | -3,100 | 36,133 | -8% | -$50,783 | ||||||
2025-02-12 | STIM | Neuronetics, Inc. | Furlong Stephen | EVP, CFO, Treasurer | S - Sale | $3.83 | -10,845 | 471,727 | -2% | -$41,536 | ||||||
2025-02-12 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, GC, CCO, CS | S - Sale | $3.83 | -12,175 | 388,647 | -3% | -$46,630 | ||||||
2025-02-11 | INSP | Inspire Medical Systems, Inc. | Rondoni John | CTO | S - Sale | $170.49 | -583 | 10,424 | -5% | -$99,396 | ||||||
| AM | 2025-01-21 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $8.92 | +530 | 8,839,380 | 0% | +$4,725 | |||||
2025-02-12 | BSX | Boston Scientific Corp | Sorenson John Bradley | EVP, Global Operations | S - Sale | $105.06 | -6,389 | 24,293 | -21% | -$671,249 | ||||||
2025-02-12 | BSX | Boston Scientific Corp | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $105.06 | -13,022 | 28,454 | -31% | -$1,368,073 | ||||||
2024-12-03 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | P - Purchase | $90.29 | +50 | 177,757 | 0% | +$4,515 | ||||||
2024-12-10 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $89.97 | -20 | 177,757 | 0% | -$1,799 | ||||||
| D | 2025-02-12 | BSX | Boston Scientific Corp | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $105.07 | -15,087 | 241,451 | -6% | -$1,585,135 | |||||
2025-02-11 | BSX | Boston Scientific Corp | Ludwig Edward J | Dir | S - Sale | $105.49 | -12,000 | 24,398 | -33% | -$1,265,815 | ||||||
2025-02-10 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, GC, CCO, CS | S - Sale | $3.28 | -1,970 | 400,822 | 0% | -$6,462 | ||||||
2025-02-10 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $3.28 | -40,992 | 1,283,362 | -3% | -$134,454 | ||||||
2025-02-10 | STIM | Neuronetics, Inc. | Furlong Stephen | EVP, CFO, Treasurer | S - Sale | $3.28 | -14,836 | 482,572 | -3% | -$48,662 | ||||||
2025-02-10 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | S - Sale | $3.27 | -3,000 | 141,053 | -2% | -$9,798 | ||||||
2025-02-12 | BDX | Becton Dickinson & Co | Scott Bertram L | Dir | S - Sale | $227.99 | -700 | 36,033 | -2% | -$159,593 | ||||||
2025-02-10 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $238.98 | -1,000 | 91,864 | -1% | -$238,980 | ||||||
| D | 2025-02-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $236.77 | -8,009 | 457,562 | -2% | -$1,896,307 | |||||
2025-02-10 | BDX | Becton Dickinson & Co | Henderson Jeffrey William | Dir | P - Purchase | $233.62 | +1,500 | 8,030 | +23% | +$350,430 | ||||||
2025-02-07 | BSX | Boston Scientific Corp | Sorenson John Bradley | EVP, Global Operations | S - Sale | $104.97 | -6,528 | 26,449 | -20% | -$685,244 | ||||||
2025-02-10 | SRTS | Sensus Healthcare, Inc. | Rampolla Javier | CFO | P - Purchase | $5.95 | +501 | 40,745 | +1% | +$2,981 | ||||||
2025-02-10 | SRTS | Sensus Healthcare, Inc. | Sardano Michael | Pres, GC | P - Purchase | $5.95 | +1,000 | 115,839 | +1% | +$5,950 | ||||||
2025-02-06 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $11.49 | -27,453 | 867,677 | -3% | -$315,435 | ||||||
2025-02-05 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $11.95 | -43,459 | 6,326,672 | -1% | -$519,335 | ||||||
2025-02-05 | TLSI | Trisalus Life Sciences, Inc. | Young James Emmett | CFO | P - Purchase | $5.65 | +6,000 | 51,726 | +13% | +$33,900 | ||||||
2025-02-03 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $16.51 | -337 | 126,424 | 0% | -$5,562 | ||||||
2025-02-03 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $3.64 | -4,000 | 378,284 | -1% | -$14,558 | ||||||
2025-02-05 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $242.11 | -2,000 | 77,218 | -3% | -$484,220 | ||||||
| M | 2025-02-03 | OFIX | Orthofix Medical Inc. | Gillespie Geoffrey C | CAO | S - Sale | $17.85 | -954 | 39,136 | -2% | -$17,026 | |||||
| A | 2025-01-31 | SYK | Stryker Corp | Stryker Ronda E | Dir, 10% | S - Sale | $392.75 | -236,000 | 3,607,467 | -6% | -$92,688,579 | |||||
| D | 2025-02-03 | BSX | Boston Scientific Corp | Butcher Arthur C | EVP,Grp Pres, MedSurg, APAC | S - Sale+OE | $101.80 | -17,313 | 18,866 | -48% | -$1,762,507 | |||||
2025-02-03 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $11.42 | -36,256 | 735,074 | -5% | -$414,044 | ||||||
2025-02-03 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $242.42 | -64 | 8,974 | -1% | -$15,515 | ||||||
2025-02-03 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.77 | +18,227 | 15,869,135 | 0% | +$14,082 | ||||||
| D | 2025-01-31 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale+OE | $17.00 | -13 | 59,019 | 0% | -$221 | |||||
| D | 2025-01-31 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | P - Purchase | $17.00 | +33,350 | 59,019 | +130% | +$566,950 | |||||
| DM | 2025-01-30 | GUTS | Fractyl Health, Inc. | Rajagopalan Harith | CEO | S - Sale+OE | $1.84 | -111,920 | 1,094,309 | -9% | -$206,003 | |||||
| DM | 2025-01-30 | GUTS | Fractyl Health, Inc. | Caplan Jay David | Pres, Chief Product Officer | S - Sale+OE | $1.88 | -43,818 | 631,160 | -6% | -$82,266 | |||||
| D | 2025-01-31 | BBNX | Beta Bionics, Inc. | Wellington Hadley Harbor Aggregator Iv, L.P. | 10% | P - Purchase | $17.00 | +1,000,000 | 3,901,599 | +34% | +$17,000,000 | |||||
| D | 2025-01-31 | SYK | Stryker Corp | Stryker Ronda E | Dir, 10% | S - Sale+OE | $392.24 | -201,392 | 17,981,466 | -1% | -$78,993,068 | |||||
2025-01-31 | MMM | 3M Co | Clarke Victoria | EVP, Chief Public Affairs Off | S - Sale | $154.22 | -1,750 | 194 | -90% | -$269,878 | ||||||
2025-01-31 | SSII | Ss Innovations International, Inc. | Srivastava Sudhir | COB, CEO, 10% | S - Sale | $1.37 | -182,216 | 96,455,158 | 0% | -$250,000 | ||||||
2025-01-30 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $45.01 | -1,100 | 318,652 | 0% | -$49,511 | ||||||
| M | 2025-01-29 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $12.03 | -93,313 | 6,370,131 | -1% | -$1,122,555 | |||||
| M | 2025-01-29 | NPCE | Neuropace Inc | Morrell Martha | Chief Medical officer | S - Sale | $15.00 | -300 | 86,762 | 0% | -$4,500 | |||||
| M | 2025-01-29 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $5.15 | +10,040 | 444,259 | +2% | +$51,754 | |||||
| D | 2025-01-29 | VTAK | Catheter Precision, Inc. | Colombatto Martin J | Dir | S - Sale+OE | $0.40 | -3 | 57 | -5% | -$1 | |||||
2025-01-29 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $86.91 | -2,090 | 83,526 | -2% | -$181,650 | ||||||
2025-01-29 | DXCM | Dexcom Inc | Dolan Matthew Vincent | EVP, Strategy, Corporate Dev | S - Sale | $86.91 | -1,183 | 42,044 | -3% | -$102,820 | ||||||
2025-01-29 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $86.91 | -2,093 | 74,261 | -3% | -$181,911 | ||||||
2025-01-29 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP, COO | S - Sale | $86.91 | -2,634 | 315,940 | -1% | -$228,932 | ||||||
2025-01-29 | DXCM | Dexcom Inc | Sayer Kevin R | COB, CEO, Pres | S - Sale | $86.91 | -33,359 | 319,037 | -9% | -$2,899,367 | ||||||
| D | 2025-01-29 | MMM | 3M Co | Roman Michael F | COB | S - Sale+OE | $152.30 | -49,598 | 180,895 | -22% | -$7,553,577 | |||||
2025-01-29 | SSII | Ss Innovations International, Inc. | Srivastava Sudhir | COB, CEO, 10% | S - Sale | $1.37 | -1,093,294 | 96,637,374 | -1% | -$1,499,999 | ||||||
| DM | 2025-01-27 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $5.27 | +9,542 | 434,219 | +2% | +$50,303 | |||||
| DM | 2025-01-27 | TLSI | Trisalus Life Sciences, Inc. | Murphy Sean | Chief Manuf, Strategy, Bus Dev | P - Purchase | $5.24 | +30,000 | 618,555 | +5% | +$157,200 | |||||
| D | 2025-01-27 | TLSI | Trisalus Life Sciences, Inc. | Young James Emmett | CFO | P - Purchase | $5.40 | +24,000 | 45,726 | +110% | +$129,600 | |||||
| M | 2025-01-27 | FNA | Paragon 28, Inc. | Mvm Partners, LLC | 10% | S - Sale | $11.86 | -111,465 | 10,229,518 | -1% | -$1,322,073 | |||||
2024-12-09 | RCEL | Avita Medical, Inc. | Crowe Suzanne | Dir | P - Purchase | $13.15 | +486 | 36,912 | +1% | +$6,391 | ||||||
| M | 2025-01-27 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $41.63 | -13,458 | 319,752 | -4% | -$560,230 | |||||
2025-01-24 | NPCE | Neuropace Inc | Morrell Martha | Chief Medical officer | S - Sale | $15.01 | -3,200 | 87,062 | -4% | -$48,032 | ||||||
2025-01-27 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.81 | +12,445 | 15,850,908 | 0% | +$10,105 | ||||||
| D | 2025-01-27 | MMM | 3M Co | Rhodes Kevin H | EVP, Chief Legal Off, Secret | S - Sale+OE | $149.85 | -6,743 | 4,902 | -58% | -$1,010,416 | |||||
| D | 2025-01-27 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $149.41 | -3,634 | 4,755 | -43% | -$542,957 | |||||
| D | 2025-01-27 | MMM | 3M Co | Chavez Rodriguez Beatriz Karina | Group Pres | S - Sale+OE | $150.25 | -1,645 | 7,362 | -18% | -$247,163 | |||||
| D | 2025-01-27 | MMM | 3M Co | Banovetz John Patrick | EVP | S - Sale+OE | $151.37 | -4,798 | 26,549 | -15% | -$726,249 | |||||
| M | 2025-01-23 | FNA | Paragon 28, Inc. | Mvm Partners, LLC | 10% | S - Sale | $11.61 | -45,162 | 10,340,983 | 0% | -$524,278 | |||||
| D | 2025-01-24 | MMM | 3M Co | Reinseth Theresa E | SVP, CAO | S - Sale+OE | $149.95 | -2,309 | 4,975 | -32% | -$346,241 | |||||
| D | 2025-01-24 | MMM | 3M Co | Goralski Christian T Jr | Group Pres | S - Sale+OE | $149.43 | -6,318 | 1,369 | -82% | -$944,070 | |||||
| D | 2025-01-24 | MMM | 3M Co | Roman Michael F | COB | S - Sale+OE | $150.01 | -45,276 | 175,718 | -20% | -$6,791,885 | |||||
2025-01-23 | AVGR | Avinger Inc | Subainati Nabeel Paul | VP, Finance | S - Sale | $0.56 | -1,255 | 3,296 | -28% | -$699 | ||||||
2025-01-23 | AVGR | Avinger Inc | Soinski Jeffrey M | CEO | S - Sale | $0.56 | -3,690 | 55,265 | -6% | -$2,054 | ||||||
2025-01-23 | AVGR | Avinger Inc | Patel Himanshu | CTO | S - Sale | $0.56 | -2,215 | 39,062 | -5% | -$1,233 | ||||||
| M | 2025-01-23 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $41.65 | -2,271 | 333,210 | -1% | -$94,578 | |||||
2025-01-21 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $12.00 | -6,687 | 5,762,615 | 0% | -$80,244 | ||||||
| M | 2025-01-21 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $8.92 | +530 | 8,961,259 | 0% | +$4,725 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |